Rutacid Chewable pills, 500mg, # 60

Release form, composition and packaging

Chewable tablets

1 tab.

hydrotalcite

500 mg

mannitol, sodium saccharinate, sodium carboxymethyl starch, talc, magnesium stearate, mint flavor.

10 pieces.

- contoured cell packages (2) - cardboard packs. 10 pcs.

- contoured cell packs (6) - cardboard packs. Pharmacological action Antacid.

Hydrotalcite has a layered network structure with a low content of aluminum and magnesium.

Neutralizes hydrochloric acid, lowers the acidity of gastric juice reduces the proteolytic activity of pepsin, binds bile acids. It has a protective effect on the gastric mucosa. Pharmacokinetics The release of magnesium and aluminum occurs gradually in the stomach, depending on the pH level of gastric juice. It is absorbed in the small intestine. After oral administration, the level of magnesium and aluminum in plasma temporarily increases, but penetration into the nervous and bone tissue does not occur (with normal renal function). The absorbed part is excreted by the kidneys. Indications for use Acute and chronic gastritis, acute and chronic duodenitis, gastric ulcer and duodenal ulcer, reflux esophagitis, epigastric discomfort or pain, heartburn after excessive consumption of alcohol, nicotine, diet errors,taking medications Contraindications for use Renal failure, children under 6 years of age, hypersensitivity to hydrotalcite. Dosage regimen When taken orally, a single dose for adults is 0.5-1 g after meals, at bedtime or when symptoms appear. In children aged 6-12 years, use half the dose for adults.

The frequency of admission and the duration of treatment are determined individually. Side effect Possible: when used in high doses - belching, diarrhea. Drug interaction With simultaneous use, the absorption of tetracyclines, iron, fluoride, fluoroquinolones decreases. Use during pregnancy and lactation. Confirmed data on the negative effect of hydrotalcite during pregnancy and in period of lactation (breastfeeding) are absent. Special instructions In case of impaired renal function, prolonged use in high doses should be avoided.

Name ENG

RUTACID

ATX code

Hydrotalcite

Dosage

500 mg

Structure

Active ingredient: hydrotalcite 500 mg

Excipients: mannitol - 836 mg

sodium saccharinate - 0.6 mg

sodium carboxymethyl starch - 12 mg

talc - 35 mg

magnesium stearate - 14 mg

mint flavor - 2.4 mg

Indications

Acute and chronic gastritis, acute and chronic duodenitis, gastric ulcer and duodenal ulcer, reflux esophagitis, discomfort or pain in the epigastrium, heartburn after excessive consumption of alcohol, nicotine, inaccuracies in the diet, taking medicines.

Contraindications

Renal failure, children under 6 years of age, hypersensitivity to hydrotalcite.

INN / Active ingredient

hydrotalcite

Storage conditions and periods

At a temperature not exceeding 30 ° C Shelf life 5 years.

Specifications

Category

Heartburn

Scope of the drug

Gastrointestinal tract

Release form

Tablet

Package quantity, pcs

60

Scope of application

Gastroenterology

Minimum age from

6 years

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

KRKA

Dosage form

Cream for external use

The target audience

Children

Dosage (volume) of the substance in the preparation

500 mg

Expiration date in days

1825

Package weight, g

65

Mode of application

:

Inside, chewing thoroughly. < br> < br> Adults and children over 12 years old: 1-2 tablets 1 hour after meals 3-4 times a day and before bedtime. < br> < br> Children from 6 to 12 years old : 1 tablet 2 times a day. < br> < br> Treatment should be continued for 4 weeks.